Improved perioperative glycemic control by continuous insulin infusion under supervision of an endocrinologist does not increase costs in patients with diabetes

Endocrine Practice

Volumn 10, Issue 2, 2004, Pages 112-118

  Vora, Amit C ^a   Saleem, Tipufaiz M ^b   Polomano, Rosemary C ^b   Eddinger, Victoria L ^b   Hollenbeak, Christopher S ^b   Girdharry, Dexter T ^b   Joshi, Renu ^c   Martin, Donal ^b   Gabbay, Robert A ^d  

^a Ambulatory Care Center   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c Pinnacle Health System   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ECONOMICS; ENDOCRINOLOGY; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HUMAN; INSULIN INFUSION; LENGTH OF STAY; METABOLISM; METHODOLOGY; PATIENT REFERRAL; POSTOPERATIVE CARE; PREOPERATIVE CARE;

BLOOD GLUCOSE; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; ENDOCRINOLOGY; HEALTH CARE COSTS; HUMANS; INSULIN INFUSION SYSTEMS; LENGTH OF STAY; POSTOPERATIVE CARE; PREOPERATIVE CARE; REFERRAL AND CONSULTATION;

EID: 4344665958     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.10.2.112     Document Type: Article

References (29)

1. The Bypass Angioplasty Revascularization Investigation (BARI) Study Group. Infl uence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. Circulation. 1997;96:1761-1769.
2. Niles NW, McGrath PD, Malenka D, et al (Northern New England Cardiovascular Disease Study Group). Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. J Am Coll Cardiol. 2001;37:1008-1015.
3. Thourani VH, Weintraub WS, Stein B, et al. Infl uence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1999;67:1045-1052.
4. Cohen Y, Raz I, Merin G, Mozes B. (Israeli Coronary Artery Bypass [ISCAB] Study Consortium). Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Am J Cardiol. 1998;81:7-11.
5. Carson JL, Scholz PM, Chen AY, et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002;40:418-423.
6. Pomposelli JJ, Baxter JK, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enteral Nutr. 1998;22: 77-81.
7. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997;63:356-61.
8. Yue DK, McLennan S, Marsh M, et al. Effects of experimental diabetes, uremia and malnutrition on wound healing. Diabetes. 1987;36:295-299.
9. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259-265.
10. Black CT, Hennessey PJ, Andrassy RJ. Short-term hyperglycemia depresses immunity through non-enzymatic glycosylation of circulating immunoglobulins. J Trauma. 1990;30:830-833.
11. Hostetter M. Effects of hyperglycemia on C3 and candida albicans. Diabetes. 1990;39:271-275.
12. Hennessey PJ, Black CT, Andrassy RJ. Nonenzymatic glycosylation of immunoglobulin G impairs complement fi xation. J Parenter Enteral Nutr. 1991;15:60-64.
13. McManus LM, Bloodworth RC, Prihoda TJ, Blodgett JL, Pinckard RN. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol. 2001;70: 395-404.
14. Kwoun MO, Ling PR, Lydon E, et al. Immunologic effects of acute hyperglycemia in nondiabetic rats. J Parenter Enteral Nutr. 1997;21:91-95.
15. Nakamura M, Morikawa M, Koika H, et al. Reduction in cellular immunity in diabetics receiving coronary artery bypass grafting. Nippon Kyobu Geka Gakkai Zasshi. 1994;42:1875-84.
16. Rassias A, Marrin CA, Arruda J, et al. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg. 1999;88:1011-1016.
17. Rassias AJ, Givan AL, Marrin CAS, et al. Insulin increases neutrophil count and phagocytic capacity after cardiac surgery. Anesth Analg. 2002;94:1113-1119.
18. Das UN. Is insulin an antiinfl ammatory molecule? Nutrition. 2001;17:409-413.
19. Dandona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an antiinfl ammatory effect? J Clin Endocrinol Metab. 2001;86: 3257-3265.
20. Van-den-Berghe G, Outers P, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;19: 1359-67.
21. Malmberg K, Norhammer A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999;99:2626-2632.
22. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-362.
23. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997;157:545-52.
24. Nichols GA, Brown JB. The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes. Diabetes Care. 2002;25:482-486.
25. Hollenbeak CS, Murphy DM, Koenig S, et al. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest. 2000;118:397-402.
26. Levetan CS, Salas JR, Wilets IF, Zumoff B. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med. 1995;99:22-28.
27. McAlister FA, Man J, Bistritz L, Amad H, Tandon P. Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care. 2003;26:1518-1524.
28. Markovitz LJ, Wiechmann RJ, Harris N, et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocrine Practice. 2002;8:10-18.
29. Outman YH, Sharma MB, Rangel MD, Walker SM, Magee. A standardized nurse-adjusted insulin infusion algorithm (SIIA) is safe and effective. Diabetes Care. 2002; 51 (Suppl 2). Abstract 447-P.